|
|
||||||||
1Department of Bioengineering, University of California-San Diego, and 2La Jolla Bioengineering Institute, La Jolla, California; and 3Advanced Research Institute for Science and Engineering, Waseda University, Tokyo, Japan
Submitted 1 October 2004 ; accepted in final form 18 November 2004
The oxygen transport capacity of phospholipid vesicles encapsulating purified Hb (HbV) produced with a PO2 at which Hb is 50% saturated (P 50 ) of 8 (HbV8) and 29 mmHg (HbV29) was investigated in the hamster chamber window model by using microvascular measurements to determine oxygen delivery during extreme hemodilution. Two isovolemic hemodilution steps were performed with 5% recombinant albumin (rHSA) until Hct was 35% of baseline. Isovolemic exchange was continued using HbV suspended in rHSA solution to a total [Hb] of 5.7 g/dl in blood. P50 was modified by coencapsulating pyridoxal 5'-phosphate. Final Hct was 11% for the HbV groups, with a plasma [Hb] of 2.1 ± 0.1 g/dl after exchange with HbV8 or HbV29. A reference group was hemodiluted to Hct 11% with only rHSA. All groups showed stable blood pressure and heart rate. Arterial oxygen tensions were significantly higher than baseline for the HbV groups and the rHSA group and significantly lower for the HbV groups compared with the rHSA group. Blood pressure was significantly higher for the HbV8 group compared with the HbV29 group. Arteriolar and venular blood flows were significantly higher than baseline for the HbV groups. Microvascular oxygen delivery and extraction were similar for the HbV groups but lower for the rHSA group (P < 0.05). Venular and tissue PO2 were statistically higher for the HbV8 vs. the HbV29 and rHSA groups (P < 0.05). Improved tissue PO2 is obtained when red blood cells deliver oxygen in combination with a high- rather than low-affinity oxygen carrier.
oxygen-carrying capacity; blood substitutes; tissue oxygen; hemoglobin oxygen affinity
This article has been cited by other articles:
![]() |
K. Taguchi, Y. Urata, M. Anraku, T. Maruyama, H. Watanabe, H. Sakai, H. Horinouchi, K. Kobayashi, E. Tsuchida, T. Kai, et al. Pharmacokinetic Study of Enclosed Hemoglobin and Outer Lipid Component after the Administration of Hemoglobin Vesicles as an Artificial Oxygen Carrier Drug Metab. Dispos., July 1, 2009; 37(7): 1456 - 1463. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cabrales, A. G. Tsai, R. M. Winslow, and M. Intaglietta Extreme hemodilution with PEG-hemoglobin vs. PEG-albumin Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2392 - H2400. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sakai, P. Cabrales, A. G. Tsai, E. Tsuchida, and M. Intaglietta Oxygen release from low and normal P50 Hb vesicles in transiently occluded arterioles of the hamster window model Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2897 - H2903. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |